Clinical Trial Update: Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated adding vildagliptin to metformin in patients with type 2 diabetes mellitus inadequately controlled on metformin; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type-2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2017-04-10